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Background: DNA methylation and histone 3 lysine 9 (H3K9) methylation are considered as epigenetic marks that
can be inherited through cell divisions. To explore the functional consequences and stability of these modifications,
we employed targeted installment of DNA methylation and H3K9 methylation in the vascular endothelial growth
factor A (VEGF-A) promoter using catalytic domains of DNA or H3K9 methyltransferases that are fused to a zinc
finger protein which binds a site in the VEGF-A promoter.
Results: Expression of the targeted DNA and H3K9 methyltransferases caused dense deposition of DNA methylation
or H3K9 di- and trimethylation in the promoter of VEGF-A and downregulation of VEGF-A gene expression. We
did not observe positive feedback between DNA methylation and H3K9 methylation. Upon loss of the targeted
methyltransferases from the cells, the epigenetic marks, chromatin environment, and gene expression levels
returned to their original state, indicating that both methylation marks were not stably propagated after their installment.
Conclusions: The clear anti-correlation between DNA or H3K9 methylation and gene expression suggests a direct
role of these marks in transcriptional control. The lack of maintenance of the transiently induced silenced chromatin
state suggests that the stability of epigenetic signaling is based on an epigenetic network consisting of several
molecular marks. Therefore, for stable reprogramming, either multivalent deposition of functionally related epigenetic
marks or longer-lasting trigger stimuli might be necessary.Background
Although (almost) all cell types in a multicellular organism
contain the same genetic information, they are function-
ally and morphologically different. Such diversity can only
be attained with highly regulated spatial and temporal
control of gene expression enacted by the so-called epi-
genetic mechanisms. Epigenetics is currently understood
by most researchers as a process for generation of her-
itable but reversible signals that do not alter the DNA
sequence. These epigenetic mechanisms extend the infor-
mation content of the genome and mediate the heritable
propagation of transcriptional cellular programs and cellu-
lar identity, which is a cornerstone of organismic develop-
ment [1-5]. Examples of inherited epigenetic signals [6]* Correspondence: albert.jeltsch@ibc.uni-stuttgart.de
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unless otherwise stated.include imprinting and X-chromosome inactivation in
mammals [7,8], and trans-generational inheritance of epi-
genetic states recently shown in plants [9] or worms [10].
Epigenetic signaling is not only essential for normal devel-
opment but it plays a central role in the onset of diseases
including cancer as well [11-14].
DNA methylation and post-translational modifications
(PTMs) of histones are critical epigenetic signals. In mam-
malian cells, the DNA molecules can be modified by
methylation at the 5 position of cytosines, typically in a
CpG dinucleotide context, which in turn can be oxidized
to 5-hydroxymethylcytosine and higher oxidation states
[15]. In a similar vein, the N-terminal tails of histones can
be massively modified, including methylation of lysine and
arginine residues, acetylation of lysine, phosphorylation of
serine and threonine, as well as ubiquitylation and sumoy-
lation of lysines [4]. DNA methylation of CpG islands in
gene promoters is correlated with gene repression, whilst
DNA methylation of gene bodies is associated with genentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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can be associated with silenced chromatin states (such as
H3K9me3, H4K20me3, and H3K27me3) but others occur
on actively transcribed chromatin (such as acetylation of
histone H3 and H4, H3K4me2/3, and H3K36me3). The
transmission of epigenetic marks over cell divisions can be
explained by different molecular models: in the case of
DNA methylation at palindromic CpG sites, the modifica-
tion occurs on both strands of the DNA and after DNA
replication, the hemimethylated sites can be specifically
emethylated by DNA methyltransferase (Dnmt) 1 in a
process of maintenance methylation [3,5]. For the
maintenance of histone modifications, models propose
a stochastic distribution of old modified histones on
the two DNA daughter strands after replication and
additional incorporation of new histones. Afterwards,
the modification state can be copied from the old his-
tones to the new ones by epigenetic ‘readers’, which
bind a particular mark and then recruit a modifier, set-
ting this mark. For example, in the case of H3K9
methylation, the HP1 protein binds di- and trimethyla-
tion lysine 9 moieties and then recruits the SUV39H1
and H2 enzymes, which can introduce H3K9me2 and
H3K9me3 on nearby H3-tails [2,3].
The central role of epigenetic signaling in diseases, to-
gether with the principle reversibility of epigenetic states,
has raised much interest in epigenetic editing approaches
aiming to specifically modulate epigenetic states. One way
to approach this is to use chimeric enzymes consisting of
a targeting module that specifically binds defined DNA se-
quences (such as zinc fingers, transcription activator-like
effectors (TALEs), or CRISPRs) and an effector domain
that harbors a defined epigenetic activity, such as catalytic
domains of DNA- or histone methyltransferases [18]. In
the past years, a number of proof of principle studies have
validated the feasibility of epigenetic editing in reporter
plasmids, viral DNA, and endogenous targets (reviewed
in [18]) and paved the way towards more comprehen-
sive studies. These include zinc finger-targeted DNA
methylation [19-22], TALE-targeted DNA demethyla-
tion [23,24], TALE-targeted H3K4me2 demethylation
[25], or zinc finger-targeted H3K9 methylation [26,27].
However, the stability and heritability of such epigen-
etic editing remained an unsolved question.
In this study, we have successfully designed and
employed adenoviral vectors harboring a zinc finger pro-
tein binding to the vascular endothelial growth factor A
(VEGF-A) gene promoter, fused via a flexible linker to
the catalytic domain of a DNA or a histone H3K9 meth-
yltransferase (Figure 1). Upon transient expression of the
constructs in SKOV3 cells, we monitored the time-
course of changes of DNA and H3K9 methylation, as
well as VEGF-A gene expression and made intriguing
observations. After infection with adenoviral vectors, wedetected dense deposition of the epigenetic marks (DNA
methylation or H3K9 di- and trimethylation), which
peaked at day 5 after infection. We observed substantial
spreading of H3K9me2/3 and strong gene repression. Sur-
prisingly, after loss of expression of the targeted methyl-
transferases, the induced epigenetic marks were lost over
several days and the VEGF-A gene was reactivated to its
original level. Interestingly, after targeted histone H3K9
methylation, we observed an excessive increase of histone
acetylation during reestablishment of gene expression,
suggesting that a response of the epigenetic network led to
loss of the silencing marks and gene reactivation. Our data
show that targeted chromatin repression of endogenous
loci is attainable but difficult to maintain. It is likely that
for preservation of the repressed state either multivalent
deposition of functionally related epigenetic marks or
longer-lasting trigger stimuli are necessary.
Results
Establishment of an adenoviral system for delivery of
targeted DNA and H3K9 methyltransferases
Based on the novel achievements in genome targeting, in-
cluding the discovery of the CRISPR-Cas9-targeting sys-
tem, epigenetic reprogramming has moved into the center
of research [18,28,29]. However, up to now, the stability of
targeted epigenetic rewriting has not been studied in
depth. We used chimeric DNA and H3K9 methyltransfer-
ases consisting of a zinc finger (ZF) domain that recog-
nizes a 9-bp motif in the VEGF-A promoter coupled to
the catalytic domains of the DNA methyltransferase 3a
(Dnmt3a) (ZF-Dnmt3a-CD) or the ZF-protein lysine
methyltransferase 1D (GLP) H3K9 methyltransferase (ZF-
GLP-CD) for targeted epigenetic rewriting of the VEGF-A
locus (Figure 1A,B,C). Our aim was to study the kinetics
and stability of targeted DNA and H3K9 methylation after
transient expression and loss of these targeted methyl-
transferases. Moreover, we studied the chromatin response
to the targeted methylation and changes in the VEGF-A
gene expression. The VEGF-A gene encodes for a signal
protein involved in angiogenesis that has a critical role in
cancer growth and metastasis [30]. In SKOV3 cells, the
VEGF-A gene is expressed and its promoter is not methyl-
ated (Figure 2). The chimeric methyltransferases were de-
livered into the cells by adenoviral vectors. These vectors
do not express the adenoviral E1 and E3 proteins, which
are essential for the generation of viral particles [31].
Hence, they can infect SKOV3 cells but cannot propagate
in these cells and are degraded after some time. The con-
structs also express green fluorescence protein (GFP) as a
marker for tracking of infection and expression of the
virus-encoded genes. Upon adenoviral delivery to SKOV3
cells, we generally observed infection of >95% of all cells
based on GFP fluorescence (Additional file 1: Figure S1B).
Fluorescence-activated cell sorting (FACS) analyses of
Figure 1 Schematic overview of the strategy used in this study and time course of the expression of adenoviral-encoded genes.
(A) Adenoviral vectors harboring the genes of targeted DNA and H3K9 methyltransferases were used to infect SKOV3 cells. (B) The enzymes were
fused to a zinc finger domain which binds a site in the promoter of the VEGF-A gene. The schematic picture of the VEGF-A promoter shows the
gene structure in dark blue, an annotated CpG island in green, the zinc finger-binding site in red, and the amplicons used for bisulfite DNA
methylation analysis and ChIP-qPCR in light blue and black, respectively. Additional ChIP-qPCR amplicons located outside of the region shown
here are indicated in Figure 3. Transcription factor-binding sites to the VEGF-A promoter are indicated in Additional file 1: Figure S1A. (C) The
chimeric zinc finger-fused DNA and H3K9 methyltransferases are targeted to the VEGF-A promoter where they introduce DNA or histone H3K9
methylation. (D) Time course of the expression of adenoviral vector-encoded genes after cell infection. The adenoviral vector also expresses GFP
to allow for the FACS analysis of infection yields and follow the expression levels of virus-encoded genes. The time-course of GFP fluorescence of
all data sets analysed in this respect was similar, and its average is shown here. The data shows averages and corresponding standard errors of
the mean of 21 experiments. GFP, green fluorescence protein; ZF, zinc finger; HKMT, histone lysine methyltransferase; DNMT, DNA methyltransferase;
d, days; bp, base pair; qPCR, quantitative PCR; VEGF-A, vascular endothelial growth factor A.
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Figure 2 DNA methylation-dependent induction of silencing. (A) Example of the time-dependent deposition and loss of DNA methylation
analyzed by bisulfite sequencing. Each row indicates one sequenced clone and each column indicates one CpG site. The blue and red colors display
unmethylated and methylated CpGs, respectively. (B) Quantification of DNA methylation over time. The averages and SEM refer to the data sets shown
in Additional file 1: Figure S2. (C) Methylation level ranking based on the data sets shown in Additional file 1: Figure S2. (D) Quantification of VEGF-A
expression normalized to SDHA. The averages and SEM are based on two to three biological repeats. VEGF-A, vascular endothelial growth factor A.
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encoded genes increased after infection until a maximum
was reached at day 5. Afterwards, the expression of virus-
encoded genes declined, and it was almost lost after
10 days (Figure 1D).
Silencing induced by targeted DNA methylation is not
maintained
In a previous study, we have shown that transient transfec-
tion of a plasmid encoding a DNA methyltransferase fused
to the VEGF-A-binding zinc finger into SKOV3 cells led
to an establishment of DNA methylation and gene silen-
cing [20]. However, with transient transfection, even after
MACS purification of transfected cells, the maximal
transfection rates were not higher than 50% to 80%.
We wanted to extend this study in two ways: first, our
aim was to introduce the chimeric DNA methyltrans-
ferase (ZF-Dnmt3a-CD) into the vast majority of cells
via adenoviral delivery. Second, following the adeno-
viral infection, we wanted to monitor the changes in
DNA methylation and expression state of the VEGF-A
promoter over time. After ZF-Dnmt3a-CD delivery, we
observed a gradual elevation of DNA methylation from
day 1 after infection onwards (Additional file 1: FigureS2 and Figure 2A,B,C). The methylation signal peaked
at day 5 with similar methylation levels, as observed
previously after transient transfection of a similar tar-
geting construct [20]. Since H3K9me3 is a silencing
mark correlated with DNA methylation, we investigated
if DNA methylation would induce deposition of H3K9
methylation. However, chromatin immunoprecipitation
quantitative PCR (ChIP-qPCR) analyses of mononu-
cleosomes isolated at day 5 from the infected cells
showed no changes of H3K9me3 methylation, indicating
that a crosstalk did not occur (Additional file 1: Figure
S8A). After the 5-day period of incremental increase in
DNA methylation, we observed a gradual loss of DNA
methylation, which returned to its basal levels at day 15
(Additional file 1: Figure S2 and Figure 2A,B,C), indicating
that DNA methylation levels directly correspond to the
expression levels of the virus-encoded targeted DNA
methyltransferase (Figure 1D). We also monitored the
levels of VEGF-A gene expression upon deposition of
DNA methylation. Interestingly, we observed a strong re-
duction of mRNA levels, most notably at day 5, followed
by a gradual re-activation of the gene until day 10 to 15
(Figure 2D). Hence, the time course of VEGF-A gene
downregulation and re-expression mirrored exactly the
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(Figure 2). The specificity of the targeted DNA methyla-
tion and repression was confirmed with several control vi-
ruses, including one construct in which the zinc finger
was fused to a catalytically inactive Dnmt3a-CD variant
(ZF-Dnmt3a-CD E752A) and constructs with ZF only,
untargeted Dnmt3a-CD or empty vector (EV) (Additional
file 1: Figure S3). To conclude, these data indicate a direct
link between deposition of DNA methylation and gene
silencing, with methylation and silencing levels com-
parable to previous results [20]. However, somehow un-
expectedly, both the methylation and gene repression
were not maintained upon loss of the targeted fusion
DNA methyltransferase.
Silencing can be induced by targeted H3K9 methylation
but it is not maintained as well
The question whether histone PTMs are drivers or con-
sequences of chromatin processes is a cardinal scientific
issue that has been hotly debated [32]. For this reason,
we wanted to directly study the effect of the targeted in-
stallment of an individual histone PTM on gene expres-
sion and to investigate the stability of this modification
after removal of the epigenetic modifier. To this aim, we
fused the catalytic domain of the GLP H3K9 methyl-
transferase with the zinc finger protein binding to the
VEGF-A promoter (ZF-GLP-CD) and cloned this into
an adenoviral vector. After adenoviral delivery of the tar-
geted H3K9 methyltransferase, we followed the time
course of H3K9 methylation and VEGF-A gene expres-
sion. We observed a gradual deposition of H3K9me2
and H3K9me3 at the target site (Figure 3). Interestingly,
we also detected a massive spreading of both marks at
least 5 kb upstream and 15 kb downstream from the
zinc finger-binding site (Figure 3). Like DNA methyla-
tion, H3K9 methylation peaked at day 5, which was
followed by return to its basal levels, indicating that the
mark was not stably maintained. While H3K9me3
returned to initial levels at day 10, the kinetics of dis-
appearance were slower for H3K9me2, which returned
to its native state only at day 15 (Figure 3). This finding
suggests a stepwise histone demethylation after the loss
of expression of the targeted methyltransferase, in which
H3K9me2 is generated as an intermediate by demethyla-
tion of H3K9me3. We also analyzed the gene expression
of VEGF-A after targeted H3K9 methylation and found
strong gene silencing at day 5 (Figure 4A). However, the
trend of gene repression mirrored the deposition of
H3K9me3 trimethylation and expression was reestab-
lished fully at day 15 (Figure 4A). In addition, we mea-
sured the levels of histone H4 acetylation 200 bps
downstream from the zinc finger-binding site and ob-
served a strong surge of histone H4 acetylation at day 10
when the expression of the targeted methyltransferasehad declined (Figure 4B,C). This effect was not due to
changes in nucleosome occupancy, as determined by
MNase mapping (Additional file 1: Figure S5). This re-
sult suggests that a histone acetyltransferase activity is
recruited to the VEGF-A promoter by undetermined
mechanisms. Similarly as before, we did not observe
positive feedback between DNA methylation and H3K9
methylation, since no changes in DNA methylation
levels were observed after targeted H3K9 methylation
(Additional file 1: Figure S8B).
The specificity of our targeted epigenome editing was
confirmed in several control experiments with zinc finger
only or untargeted GLP catalytic domain, which both
showed only residual silencing (Additional file 1: Figure
S4). In an additional set of control studies, the zinc finger
protein was fused with two different catalytically inactive
GLP variants (ZF-GLP-CD C1201A and ZF-GLP-CD
ΔNHHC) (Additional file 1: Figure S4). These constructs
differ in their ability to interact with the endogenous G9a
H3K9 methyltransferase which forms a heterodimeric
complex with GLP in cells [33]. The GLP C1201A variant
is still able to form heterodimers with G9A but the GLP-
CD ΔNHHC is not. The slightly stronger residual silen-
cing of VEGF-A expression observed with the GLP
C1201A variant suggests that a recruitment of native G9A
by the chimeric ZF-GLP-CD protein has some enhancing
effect on gene repression in our system. We also detected
a slight increase of H3K9me3 at the VEGF-A locus with
untargeted GLP-CD (without zinc finger) at day 3, which
declined to basal levels at day 5 unlike ZF-GLP-CD,
which peaked at day 5 (Additional file 1: Figure S6-S7
and Figure 3). To conclude, our data indicate that the
downregulation of VEGF-A is a direct consequence of
H3K9me2/3 deposition and spreading and suggest that
these particular histone marks likely have a direct role
in the regulation of gene expression. In addition, as in
the case of DNA methylation, the H3K9 methylation
mark was not stably maintained and the observed gene
silencing was only transient. Interestingly, our data also
suggest that the surge of histone acetylation at day 10
is likely a feedback ‘over-reaction’ from the cellular epigen-
etic network, which overrides the repressive state and
leads to gene reactivation.
Loss of DNA and H3K9 methylation is not due to a
growth disadvantage of cells caused by VEGF-A silencing
We wanted to determine if the loss of the DNA and
H3K9 methylation signal after 5 days could be caused by
a selective growth disadvantage of cells after VEGF-A si-
lencing. However, the gradual loss of DNA and H3K9
methylation and gene silencing observed after day 5 was
not correlated with a shift of cell populations. This is il-
lustrated by the observation that the time course of loss
of GFP expression was identical in cells infected with
Figure 3 Targeted deposition, spreading, and loss of histone H3K9 methylation over time. The black boxes indicate the location of the
amplicons used for ChIP-qPCR (also compare with Figure 1B for a larger image of the VEGF-A gene promoter). The numbers above the bars
indicate the distance of the qPCR amplicons from the zinc finger-binding site. (A) ChIP-qPCR measurements of H3K9me2 at the designated
amplicons covering the promoter and gene body of VEGF-A. (B) ChIP-qPCR measurements of H3K9me3 at the designated amplicons covering
the promoter and gene body of VEGF-A. The averages and SEM are based on two to three biological repeats. The corresponding P values can be
found in Additional file 1: Table S2. VEGF-A, vascular endothelial growth factor A; bp, base pair; ZF-GLP-CD, zinc finger-protein lysine methyltransferase
1D-catalytic domain.
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ZF alone, or viruses that encode for catalytically inactive
methyltransferases) and viruses that lead to DNA or
H3K9 methylation and corresponding gene silencing
(ZF-Dnmt3a-CD or GLP-CD virus) (Figure 4C). These
data indicate that the relative proportions of cells with
or without the adenoviral vector did not change regard-
less of whether the VEGF-A gene was silenced or not.
Hence, the loss of the DNA and H3K9 methylation mark
reflects a true loss of the signal and not a diminishment
of the cell population that carries the signal.
Discussion
The epigenome of each cell from a multicellular organism
is a highly dynamic entity that realizes the transcriptionalprograms encoded within the genome, balancing between
phenotypical stability and environmental plasticity. In this
study, we were able to provide a valuable insight into the
inner workings of chromatin by setting a defined chroma-
tin modification at an endogenous locus and following
the dynamics of its appearance and disappearance with
a spatial and temporal resolution. Previous studies have
successfully designed and applied modular DNA-
binding proteins fused with eukaryotic or prokaryotic
DNA methyltransferase activities for targeted DNA
methylation [34]. Notably, the technology involving
mammalian Dnmt catalytic domains fused to zinc finger
proteins was successfully used for targeted methylation of
endogenous promoters of cancer-associated genes, includ-
ing VEGF-A [20-22]. In previous studies performed in our
Figure 4 H3K9 methylation-dependent induction of silencing. (A) Quantification of VEGF-A expression normalized to SDHA. The averages
and SEM are based on two to three biological repeats. (B) ChIP-qPCR measurements of H4 acetylation at the promoter of VEGF-A. The averages
and SEM are based on two to three biological repeats. (C) Time course of GFP of all experiments analyzed in this respect. The dark green bars
show the average data of experiments which led to VEGF-A silencing (N = 7). The light green bars show the averages of the controls not leading
to silencing (N = 14). The error bars indicate the standard errors of the mean. VEGF-A, vascular endothelial growth factor A; GFP, green fluorescence
protein; d, days.
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delivery of the targeted DNA methyltransferases. This
allowed to transfect about 50% to 80% of all cells leading
to significant DNA methylation and gene downregulation
of the tested genes (EpCAM or VEGF-A) [20,22]. In the
current work, we extended these experiments and used an
adenoviral delivery system, which has significantly im-
proved the number of infected cells expressing the tar-
geted DNA and H3K9 methyltransferases. We observed a
clear anti-correlation between gene expression and the
DNA and H3K9 methylation levels, suggesting that these
epigenetic marks have a direct effect on gene regulation.
The viral delivery system enabled us to follow the dy-
namics of the establishment and loss of the H3K9 and
DNA methylation in the VEGF-A locus, and interest-
ingly, we observed a lack of preservation of both marks
after loss of expression of the respective targeted meth-
yltransferase. Our results indicate that activating signals
from the surrounding chromatin domain of the VEGF-A
gene overruled the local silencing signal and led to its
disappearance.
Different from our results, in a previous report, DNA
methylation introduced at the Maspin locus was stable
over multiple generations [21]. One explanation for this
discrepancy could be the chromatin context of the loci
tested, with one being more permissive to permanent si-
lencing than the other. This difference may also be attrib-
uted to the technical approach, because in the Rivenbark
study, stable cell lines were generated, which contained
the gene of the targeted methyltransferase. While it was
found that the expression levels of the chimeric methyl-
transferase were drastically reduced after several cell gen-
erations, it is still conceivable that a small amount of the
effector was still present in the cell, sufficient for the
maintenance of the silenced state.
Only a few studies prior to this one showed promise in
testing the utility of ZF-targeted histone methyltransferasesin epigenome editing [26,27,35]. Apart from validating the
general feasibility of this approach, we also monitored the
dynamics of the establishment and disappearance of the
H3K9 methylation and show lack of preservation of H3K9
methylation. Moreover, we show spreading of the modifica-
tion for at least 15 kb downstream and 5 kb upstream from
the nucleation site. Similar observations of heterochromatin
spreading were made by chemically induced recruitment of
the HP1 chromo shadow domain to an artificial promoter
[36]. In this study, the heterochromatization was inherited
only after a prolonged chemical stimulus (4.5 weeks), which
led to a local gain of DNA methylation. Similar to our
study, the presence of chemical stimulus for 3 to 7 days,
only led to a transient deposition of H3K9me3 and re-
duced transcriptional output, both of which were lost
after cessation of the inducing stimulus. In another
study in Schizosaccharomyces pombe strains, a hetero-
chromatic block of H3K9 methylation was successfully
established but lost over days which is in agreement
with our findings [35].
Conclusions
The data obtained in our experimental system indicate
that the epigenetic chromatin state can be easily edited
by setting a trigger ‘repressive’ mark, concurrently lead-
ing to gene silencing. Interestingly, after discontinuance
of the trigger signal (both in the case of DNA and H3K9
methylation), the chromatin state and transcriptional
levels shifted back to their native state. This suggests
that the maintenance and mitotic inheritance of an epi-
genetic mark, even DNA methylation, which is consid-
ered to be one of the most stable silencing signals, might
not be a trivial task. This finding is in agreement with
recent observations suggesting that the initial model of
DNA methylation inheritance in a maintenance process
was an oversimplification, and that DNA methylation is
better described by a dynamic and stochastic model [37].
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network of epigenetic marks, and they cannot be reset
easily by rewriting a single mark. To achieve this, a
multivalent deposition of functionally related epigenetic
marks or longer-lasting trigger stimuli might be necessary
(Figure 5). The epigenetic network provides feedback
regulatory mechanisms; and processes such as imprinting,
heterochromatization, or housekeeping gene transcription
are most likely continuously supported with balancing reg-
ulators in order to preserve their initial chromatin state.
Furthermore, our data show that DNA methylation and
H3K9 methylation did not enforce each other and the tar-
geted H3K9 methylation and gene silencing did not re-
duce H4 acetylation. It would be interesting to see if
additional treatment of cells with demethylase inhibitors,
generation of longer-lasting trigger signals, or combined
deposition of DNA and histone methylation could induce
mitotic stability and true epigenetic inheritance. In addition,
it is an interesting question to study the effect, stability,
and network response of the targeted deposition of an
‘activating’ chromatin mark, such as H3K4me3 or histone
acetylation. Finally, with the development of novel genome
targeting technologies, it will be compelling to observe the
effects of setting or erasing single or combinatorial epigen-
etic marks in different chromatin contexts. For this, it will
be necessary to study the stability of epigenetic repro-
gramming at several loci and learn about the influence of
the chromatin environment on the stability of gene silen-
cing. This will pave the way into true epigenetic editing in
the sense that the newly generated epigenetic states would
be as stable as the natural ones and have comparable bio-
logical effects.
Methods
Cloning and production of recombinant adenovirus
The zinc finger protein which binds a 9-bp sequence
(GGGGGTGAC) in the VEGF-A promoter [26], ZF
fused to Dnmt3a-CD (amino acids 608-908, UniProt no.Figure 5 Conclusions for the reprogramming of epigenetic states. (A) In
state and silence gene expression but the silenced state is not stable. (B) For
triggers lasting over longer times are needed.O88508), or Dnmt3a-CD alone were amplified and sub-
cloned into the pAdTrackCMV vector using the BglII and
XhoI restriction sites. The DNA fragments containing the
catalytic domain, H3K9 methyltransferase G9a-like pro-
tein (amino acids 1002-1295, UniProt no. Q96KQ7), were
cloned in empty or zinc finger-containing pAdTrackCMV
vector using the SalI and HindIII restriction sites. The
production of adenoviral vectors and adenovirus was
based on [31]. Briefly, the pAdTrackCMV vector contain-
ing the gene of interest was linearized with PmeI and was
co-transformed with pAdEasy-1 vector into Escherichia
coli BJ5183. Successful recombination was confirmed by
restriction digestion and Sanger sequencing. Six micro-
grams of PacI linearized vector was transfected into
HEK293 cells in T-25 flask. HEK293 are E1 positive, thus
allowing virus production. After transfection, the HEK293
cells were maintained in DMEM supplemented with 5%
fetal bovine serum in a CO2 incubator at 37°C for 14 to
21 days, with addition of 2 ml medium, every 4 days. The
adenoviral vector also expressed GFP to allow for the
FACS analysis of infection yields and follow the expression
levels of virus-encoded genes. The expression of GFP and
the targeted zinc finger-fused methyltransferases was both
driven by a CMV promoter. Total infection was confirmed
microscopically, and viral lysates were prepared for high-
titer virus production. In the end, the mature virus was
collected using cesium chloride (CsCl) density gradient
centrifugation and gel filtration (Nap™ columns, GE
Healthcare, Pewaukee, WI, USA), and it was used for fur-
ther infections. The optimal viral titer for infection of
SKOV3 cells was determined by serial dilutions.
Infection of SKOV3 cells with recombinant adenoviral
vectors
SKOV3 cells were obtained from ATCC (American Type
Cell culture Collection) and cultured in DMEM supple-
ment with 10% fetal bovine serum, L-glutamine, and
penicillin/streptomycin. SKOV3 cells were seeded in adividual stimuli (indicated by the purple arrow) can edit the epigenetic
stable epigenetic silencing, presumably multiple triggers or individual
Kungulovski et al. Epigenetics & Chromatin  (2015) 8:12 Page 9 of 10density of 2 × 105 cells per well in a six-well plate, and
the following day the cells were infected with the adeno-
viral vectors. Virus dilutions were selected to yield >95%
of infection without affecting the cell viability. The infection
yield was determined by measuring GFP fluorescence
(FACSCalibur, BD Biosciences, San Jose, CA, USA), where
uninfected cells were used as a control. One day post-
infection, the free virus was removed and the cells were
washed with warm PBS. The samples were collected by
trypsinization at day 3 or day 5 post-infection. Half of the
cells harvested at day 5 was propagated until day 10 or day
15. For chromatin isolation, the whole protocol was up-
scaled to 2 × 107 cells. Corresponding samples were always
used for bisulfite sequencing, chromatin immunoprecipita-
tion, and gene expression experiments. The generation of
adenoviral particles and infection of SKOV3 was done in
compliance with Biosafety Level 2 regulations.
Analysis of methylation by bisulfite conversion
Genomic DNA was isolated using the QIAmp® DNA mini
kit (Qiagen, Limburg, The Netherlands). Four hundred
nanograms of genomic DNA were digested with BamHI
overnight at 37°C, and bisulfite conversion was carried out
using sodium bisulfite and sodium hydroxide as described
[38]. After bisulfite conversion the genomic DNA was con-
centrated and purified using Amicon filters (Millipore, Bil-
lerica, MA, USA) and amplified using the following
primers: FP 5′-GTT TGT TAT TTT TTA TTT GAA T-3′
and RP 5′-AAT CAC TCA CTT TAC CCC TAT C-3′
[20]. The PCR product was subcloned using the Strata-
clone PCR cloning kit (Agilent Technologies, Santa Clara,
CA, USA) and several individual clones were sequenced.
Native chromatin immunoprecipitation (nChIP) and gene
expression
Native mononucleosomes were prepared from around
20 million SKOV3 cells by micrococcal nuclease digestion
of nuclei as described [39] with minor modifications. More
precisely, after MNase treatment, the nuclei were spun
down at 13,000g for 10 min, and the soluble nucleosomal
supernatant was collected and snap frozen. We used 10 to
15 μg (based on DNA absorbance) of pre-cleared native
chromatin per ChIP with anti-H3K9me2 (ab1220, Abcam
plc, Cambridge, UK), anti-H3K9me3 (ab8898, Abcam plc,
Cambridge, UK), or pan-H4-acetyl (AM 39243) (go to
Additional file 1: Figure S5 to see their peptide array speci-
ficity profiles). After immobilization on protein G-coated
magnetic Dynabeads (Invitrogen, Waltham, MA, USA),
the antibody-chromatin complexes were washed with: 1×
low salt buffer (20 mM Tris-Cl, 150 mM NaCl, 1% Tri-
ton × -100, 0.1% SDS, and 2 mM ethylenediaminetetraace-
tic acid (EDTA)), 1× high salt buffer (20 mM Tris-Cl,
500 mM NaCl, 1% Triton × -100, 0.1% SDS, and 2 mM
EDTA), 1× LiCl buffer (10 mM Tris-Cl, 250 mM LiCl,1% NP-40, 1% DOC, and 1 mM EDTA), and 2× TE buf-
fer. After each wash, the beads were rotated for 10 min
at +4°C. The bound nucleosomes were eluted in elution
buffer (50 mM Tris-Cl, 50 mM NaCl, 1 mM EDTA, 1%
SDS), for 45 min at room temperature with rotation. DNA
was recovered using ChIP DNA purification columns
(Active Motif, Carlsbad, CA, USA).
The quantitative PCR assays were performed on a
CFX96 Connect Real-Time detection system (Bio-Rad,
Hercules, CA, USA) using SsoFast EvaGreen supermix
(Bio-Rad, Hercules, CA, USA). In the nChIP experi-
ments, a standard curve was generated to calculate per-
cent of precipitated DNA and test the efficiency of each
primer set covering the VEGF-A locus. The primer se-
quences can be found in Additional file 1: Table S1. To
correct for technical quality between the different sam-
ples, each amplicon signal was normalized to an internal
positive control which carries the corresponding mark
and is not affected by the reprogramming (satellite alpha
or gene desert-12 amplicons in the case of H3K9me2/3
or PABPC1 amplicon in the case of pan-H4ac). To this
end, the percent of precipitated DNA was calculated for
each amplicon and then divided by the percent of precipi-
tated DNA obtained with the amplicons from the internal
positive control. For nucleosomal mapping, mononucleo-
somal DNA was compared to a standard curve from gen-
omic DNA and normalized for technical variability to an
internal control (HOX11).
For gene expression analyses, total RNA was isolated
for each time-point using the Purelink™ RNA mini kit
(Ambion, Life Technologies, Carlsbad, CA, USA) and
cDNA was prepared with oligo d(T)18 primers (New
England Biolabs, Ipswich, MA, USA) from 1 to 2 μg of
RNA. After this, qPCR was carried out using VEGF-A
specific primers (FP 5′-AGA AGG AGG AGG GCA
GAA TCA-3′ and RP 5′-ATG GCT TGA AGA TGT
ACT CG-3′), normalized to the housekeeping gene
SDHA (FP 5′-TGG GAA CAA GAG GGC ATC TG-3′
and RP 5′-CCA CCA CTG CAT CAA ATT CAT-3′).
Non-RT controls were included in all experiments, and
the total VEGF-A expression was quantified using the
2−ΔΔCT method (threshold cycle (CT)) [40].
Data analysis
Data are reported as means of biologically independent ex-
periments as indicated. Error bars indicate the correspond-
ing standard error of the mean. P values were determined
by Excel using two tailed T tests with equal variance.Additional file
Additional file 1: Supplementary Figures S1-S9 and Supplementary
Tables S1 and S2.
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